Ibnsina Pharma News - Mubasher Info
KSA
Mubasher TV
 Contact Us Advertising   العربية
KSA
TDWL Closed
10 June 09:20 AM

Ibnsina Pharma (ISPH)

Last update: 9 June 01:28 PM market time.
12.42
0.02
0.16%
Open 12.44
Previous Close 12.44
High 12.59
Low 12.38
Stock Statistics
Volume 5,147,442
Turnover 64,179,828.00
All data are 15 minutes late during market session

News

The company plans to inaugurate from three to four new branches
10 May 2020 01:27 PM Ibnsina Pharma injects EGP 250-300m new investments annually
Cairo – Mubasher: Ibnsina Pharma announced that its average investments range between EGP 250-300 million per year, except for the exceptional investments in 2018 and 2019. The company plans to inaugurate from three to four new branches every …
Companies Investments
The Egyptian firm's net profits hit EGP 328.77 million in 2019
21 April 2020 00:18 PM Ibnsina Pharma’s shareholders approve capital raise via bonus issue
Cairo – Mubasher: The extraordinary general meeting (EGM) of Ibnsina Pharma approved a proposal to increase the issued capital through a bonus issue, according to a bourse statement on Tuesday. Earlier in April, the company’s ordinary general …
General Assembly
The company’s sales grew to EGP 16.6 billion
24 February 2020 03:09 PM Ibnsina Pharma’s profit up 25% in 2019; dividends proposed
Cairo – Mubasher: Ibnsina Pharma posted a 25% year-on-year rise in its net profits during 2019. Net profits levelled up to EGP 328.77 million last year from EGP 262.5 million in the previous year, the company said in a statement to the Egyptian …
Financial Results
Net profits soared to EGP 245.6 million
4 November 2019 03:23 PM Ibnsina Pharma’s profit rises 29% in 9M
Cairo – Mubasher: The financial statements of Ibnsina Pharma reported a 28.9% year-on-year profit growth during the first nine months of 2019. Net profits soared to EGP 245.6 million during the January-September period from EGP 190.6 million in …
Financial Results
EBRD sold 11.41 million shares
9 September 2019 10:49 AM EBRD cuts stake in Ibnsina Pharma for EGP 111m
Cairo – Mubasher: Financial Brokerage Group said that the European Bank for Reconstruction and Development (EBRD) has reduced its stake in Ibnsina Pharma to 8.71% from 10.10%. EBRD sold 11.41 million of Ibnsina Pharma’s shares for a value of EGP …
Insider Trading & Treasury Stocks
The deal is EFG Hermes’ sixth equity capital market (ECM) offering in 2019
8 September 2019 02:07 PM EFG Hermes completes advisory on Ibnsina Pharma's sale deal
Cairo – Mubasher: EFG Hermes on Sunday announced the completion of its advisory on the follow-on sale of Ibnsina Pharma’s 69.1 million shares, representing 8.4% of the company’s shares on the Egyptian Exchange (EGX).   The leading financial …
Mergers and Acquisitions
The deal involved the trading of 69.11 million shares
5 September 2019 00:35 PM Ibnsina Pharma’s stock sees EGP 670.4m deal Thursday
Cairo – Mubasher: The Egyptian Exchange (EGX) announced that Ibnsina Pharma’s stock witnessed a transaction worth EGP 670.4 million on Thursday. The deal involved the trading of 69.11 million shares at EGP 9.7 per share, the EGX said in a …
Insider Trading & Treasury Stocks
Roche generated EGP 1.435 billion in sales in Egypt in 2018
2 September 2019 03:12 PM Ibnsina Pharma inks deal to distribute Roche products in Egypt
Cairo – Mubasher: Ibnsina Pharma announced signing an agreement with Roche Pharmaceuticals to import and distribute Roche products in the Egyptian market. Under the deal, Ibnsina Pharma will distribute all 40 high-technology stock keeping units …
Companies Investments
The remaining value of the rights issue proceeds totals EGP 99.6 million
19 August 2019 02:38 PM Ibnsina Pharma invests EGP 190m of rights issue proceeds
Cairo – Mubasher: Ibnsina Pharma announced that it has spent, until the end of June this year, EGP 190.4 million worth of the subscription proceeds of the capital increase, which amounted to EGP 290 million registered on 24 April 2018. In a recent …
Companies Investments
Net profits surged to EGP 103.19 million
7 August 2019 10:47 AM Ibnsina Pharma’s profit grows 35% in H1
Cairo – Mubasher: Ibnsina Pharma reported a 34.6% year-on-year profit increase during the first half of 2019. Net profits surged to EGP 103.19 million in the six-month period ended 30 June, compared to EGP 76.56 million in the year-ago period, the …
Financial Results
The pharmaceutical firm's revenues rose by 29% in Q1-19
13 May 2019 11:28 AM Pharos Research sets Ibnsina Pharma’s FV at EGP 13.5/shr
Cairo – Mubasher: Pharos Research has set the fair value (FV) of Ibnsina Pharma’s stock at EGP 13.5, with an “overweight” recommendation, according to a report released on Sunday.   The pharmaceutical firm posted a 29% year-on-year increase in …
Stock Evaluations
Sales rose to EGP 3.8 billion
12 May 2019 01:24 PM Ibnsina Pharma’s profit rises 47% in Q1
Cairo – Mubasher: Ibnsina Pharma reported a 46.6% year-on-year profit growth during the first quarter of 2019. The pharmaceutical firm’s net profits amounted to EGP 40.99 million in Q1-19, compared to EGP 27.95 million in the year-ago period, …
Financial Results
The company’s capital will be raised by SAR 24.5 million to SAR 205 million
21 April 2019 05:36 PM Ibnsina Pharma’s OGM approves dividend, bonus shares for 2018
Cairo – Mubasher: Ibnsina Pharma announced that the company’s shareholders had approved distributing a cash dividend of EGP 0.070 a share with a total value of EGP 50.89 million for 2018 during an ordinary general meeting (OGM). The OGM also …
Cash Dividends
The board proposed paying EGP 0.7 per share for FY18
7 March 2019 02:28 PM Ibnsina Pharma proposes dividends, bonus for FY18
Cairo Mubasher: The board members of Ibnsina Pharma recommended distributing a total of EGP 75.4 million as cash dividends and bonus shares for fiscal year 2018. Ibnsina Pharma’s board proposed paying EGP 0.7 per share at a value of EGP 50.88 …
Cash Dividends
Ibnsina Pharma has posted a revenue of EGP 13.6 billion in FY18
7 March 2019 01:12 PM Ibnsina Pharma FY18 profits surge to EGP 262.5m
Cairo – Mubasher: The Egyptian pharmaceutical distributor Ibnsina Pharma achieved a growth of 54% in profits during fiscal year 2018 compared to the prior year. Earnings soared to EGP 262.52 million in FY18 from EGP 170.13 million in FY17, …
Financial Results
The company logged EGP 188.3 million in the nine-month period ended September
11 November 2018 04:39 PM Ibnsina Pharma profit rises 32% in 9M
Cairo – Mubasher: Ibnsina Pharma on Sunday reported a 31.6% year-on-year increase in profits for the first nine months of 2018. The company logged EGP 188.3 million in the nine-month period ended September, versus EGP 143.1 million in the …
Financial Results
Pharos Research maintains ‘Overweight’ for Ibnsina Pharma on FV of EGP13.62/shr
15 May 2018 02:59 PM Pharos Research maintains ‘Overweight’ for Ibnsina Pharma on FV of EGP13.62/shr
Cairo – Mubasher: Pharos Research has reiterated their ‘Overweight’ recommendation for Ibnsina Pharma’s stock based on a fair value (FV) of EGP 13.62 per share. This was mainly driven by a deduction of EGP 2 per share of the FV due to a potential …
Stock Evaluations
Revenues doubled to EGP 2.9 billion in Q1-18
14 May 2018 02:40 PM Ibnsina Pharma Q1 profit hikes 46%
Cairo – Mubasher: Ibnsina Pharma on Monday reported a 46% year-on-year surge in profits for the first quarter of 2018, recording EGP 27.9 million from EGP 19.10 million. Revenues doubled to EGP 2.9 billion in Q1-18, versus EGP 1.9 billion in the …
Financial Results
The OGM endorsed 2017 financial statement
3 April 2018 00:10 PM Ibnsina Pharma OGM nods to distribute no dividends for 2017
Cairo – Mubasher: The ordinary general meeting (OGM) of Ibnsina Pharma has approved the board’s proposal of not to distribute cash dividends for 2017. The OGM endorsed 2017 financial statement and the board’s report on the company’s activities for …
Cash Dividends
Revenues are forecast to record EGP 35.7 billion by 2022
2 April 2018 03:05 PM Pharos Research sets Ibnsina Pharma’s FV at EGP 15/shr
Cairo – Mubasher: Pharos Research has set the fair value (FV) of Ibnsina Pharma’s stock at EGP 15, with a valuation gap of 48%. The pharmaceutical firm’s revenues are projected to grow 31% year-on-year to reach EGP 12.8 billion by the end of 2018, …
Stock Evaluations
This move would raise Ibnsina Pharma’s market share to 26%
22 March 2018 01:19 PM Ibnsina Pharma to invest EGP 150-200m in 5 yrs
Cairo – Mubasher: Ibnsina Pharma is planning to pump new investments range between EGP 150 million and EGP 200 million in Egypt over the next five years. This move would raise the Egypt-based drug distributor’s market share to 26% from 19.3% in …
Companies Investments
Ibnsina will benefit from adding Novo Nordisk’s products to its portfolio
20 March 2018 00:18 PM Ibnsina Pharma to distribute Novo Nordisk’s products in Egypt
Cairo – Mubasher: Ibnsina Pharma has signed two new contracts with Denmark-based Novo Nordisk to distribute more than 20 medicines to cure diabetes, haemophilia, and growth disorders. Novo Nordisk was dependant on a state-owned firm and a private …
Companies Investments
The board has proposed a distribution of EGP 8.6 million to employees
11 March 2018 03:29 PM Ibnsina Pharma proposes no dividends for 2017
Cairo – Mubasher: Ibnsina Pharma on Sunday announced that it would not distribute cash dividends to shareholders for 2017. The board has proposed a distribution of EGP 8.6 million to employees, as well as retaining EGP 8.51 million from net …
Cash Dividends
Revenues rose to around EGP 9.82 billion in 2017
11 March 2018 02:29 PM Ibnsina Pharma profit jumps 67% in 2017
Cairo – Mubasher: The audited financial statements of Ibnsina Pharma on Sunday showed a 67.2% year-on-year growth in profits for 2017. Net profit reached EGP 170.14 million last year, versus EGP 101.75 million a year earlier, the company said in a …
Financial Results
Egypt's largest drug distributor said that its market share rose by 2.38 points in 2017
21 January 2018 00:48 PM Ibnsina’s market share hikes 19.2% in 2017
Cairo - Mubasher: IMS Health on Sunday reported that Ibnsina Pharma’s market share increased to 19.24% in 2017 from 16.86% a year earlier, boosted by higher sales Egypt's largest drug distributor said that its market share rose by 2.38 points in …
Financial Results